AzTrials
AzTrials

Chronic Venous InsufficiencyVEDIPEDINCT04424095

Venous Disease in Pediatric Population

An observational study of Chronic Venous Insufficiency and Pediatric ALL, run by University of Catanzaro at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Chronic venous disease (CVD) is widespread in adult subjects of western countries and is responsible of important morbidity and healthcare costs. CVD has never been extensively studied in pediatric population where the early pathophysiological alterations may occur undetected. Read more about this study

Who is it for?
Ages 9 to 18 years
Conditions the study is for
Chronic Venous Insufficiency, Pediatric ALL
What is being tested?
In-office vascular visit and Echo Duplex of lower limbs
How many people
100 participants
Where
1 siteItaly
Study dates
1 Feb 2020to 1 Oct 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Pediatric subjects, of both sex, aged between 9 and 18 years old which are cooperative for visit and diagnostic testing.

Who may be able to join

  • Pediatric Patients

Who cannot join

  • Patients with mental retardation
  • Patients with Marfan syndrome
  • Patients with an inability to stand or collaborate for the clinical tests.

Trial locations and contacts

1 site in 1 country.

Raffaele Serra, M.D., Ph.D. contact

+3909613647380

rserra@unicz.it

Italy1 site, 1 recruiting
  • University Magna Graecia of Catanzaro

    Catanzaro, 88100

    Raffaele Serra, M.D., Ph.D., +3909613647380, rserra@unicz.it

    Recruiting

Other trials in Italy

About this study

Official title: Investigation of Chronic Venous Disease in Pediatric Population

Chronic venous disease (CVD) is widespread in adult subjects of western countries and is responsible of important morbidity and healthcare costs. CVD has never been extensively studied in pediatric population where the early pathophysiological alterations may occur undetected. The aim of this study is to assess the prevalence of CVD searching also for the early clinical and instrumental signs of this disease.

Read the detailed description

Chronic venous disease (CVD) of lower limbs for its high prevalence in adult population represents one of the main causes of morbidity in western countries, and it has also an important effect on healthcare cost absorbing 1-2% of the total health budget in western countries. Clinical manifestations related to CVD are well documented in adults, with clinical guidelines that standardize both diagnosis and treatment. Nevertheless, there is a scarcity of published data regarding CVD in children, and in addition, venous duplex ultrasound test of the lower limbs is performed much less commonly in children than in adults.

Therefore, the natural history of pediatric venous reflux remains unclear, although it is possible that it precedes the onset of CVD in adulthood. In this context, this observational study aims to identify the presence of venous reflux, as well as clinical and morphological data in pediatric subjects, aged between 9 and 18 years old, by performing an office vascular visit and an echo duplex scan of lower limbs. The endpoints of this study are to prospectively assess the prevalence of CVD in children, as well as to evaluate a possible correlation between vein diameter and pathological vein reflux.

Being tested
In-office vascular visit, Echo Duplex of lower limbs
Keywords
Chronic venous disease, Pediatrics, vein reflux
Medical subject headings
Precursor Cell Lymphoblastic Leukemia-Lymphoma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • In-office vascular visitDiagnostic test

    The patient will be examined to search for signs or symptoms of chronic venous disease (teleangiectasia, reticular veins, varicose veins, skin changes, pain, itching, heavy legs, ankle edema)

  • Echo Duplex of lower limbsDiagnostic test

    The venous system of lower limbs will be checked in order to detect any vein dilation and reflux.

Study groups in NCT04424095
Study groupRoleWhat they receive
Pediatric patientsRecruited pediatric patients will undergo an in-office vascular visit and an echo duplex scan of lower limbs, in order to detect any symptoms or signs related to chronic venous disease.
Receives: Diagnostic Test: In-office vascular visit; Diagnostic Test: Echo Duplex of lower limbs

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of Chronic Venous Disease

    The Prevalence of Chronic Venous Disease in the population study will be assessed.

    Measured: at 9 month

  2. Echo duplex evaluation

    The correlation between veins diameter and the presence of reflux will be evaluated in pediatric population

    Measured: at 10 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2020
  2. Study start1 Feb 2020
  3. Primary completion1 Sep 2020 (estimated)
  4. Study completion1 Oct 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04424095
Sponsor's protocol ID
ER.ALL.2018.21
Acronym
VEDIPEDI
Status last verified
Jun 2020
First submitted
6 Jun 2020
Last updated
9 Jun 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Robertson L, Evans C, Fowkes FG. Epidemiology of chronic venous disease. Phlebology. 2008;23(3):103-11. doi: 10.1258/phleb.2007.007061.

    PubMed 18467617
  • Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005 Mar;15(3):175-84. doi: 10.1016/j.annepidem.2004.05.015.

    PubMed 15723761
  • Griffiths L, Vasudevan V, Myers A, Morganstern BA, Palmer LS. The role of inheritance in the development of adolescent varicoceles. Transl Androl Urol. 2018 Dec;7(6):920-925. doi: 10.21037/tau.2018.09.02.

    PubMed 30505728

Questions about this trial

What is this clinical trial studying?

An observational study of Chronic Venous Insufficiency and Pediatric ALL, run by University of Catanzaro at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Raffaele Serra, M.D., Ph.D. (+3909613647380, rserra@unicz.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of Chronic Venous Disease (time frame: at 9 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04424095, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in